2678results about How to "Accurate diagnosis" patented technology

A system for monitoring a patient's vital signs that features a vital-sign monitor including sensors for measuring from the patient at least one of the following vital-sign data: O₂ saturation, blood pressure, electro-cardiogram, respirator rate, and blood glucose level. The system also includes a global positioning system that determines location-based data. A wireless transmitter, in electrical contact with the vital-sign monitor and global positioning system, receives the vital-sign and location-based data and wirelessly transmits these data through a conventional wireless network. A gateway software piece receives and processes the data from the wireless network and stores these data in a computer memory associated with a database software piece. The system also includes an Internet-based user interface that displays the vital sign data for both individual patients and care-providers.

A system for monitoring a patient's vital signs that features a vital-sign monitor including sensors for measuring from the patient at least one of the following vital-sign data: O₂ saturation, blood pressure, electrocardiogram, respirator rate, and blood glucose level. The system also includes a global positioning system that determines location-based data. A wireless transmitter, in electrical contact with the vital-sign monitor and global positioning system, receives the vital-sign and location-based data and wirelessly transmits these data through a conventional wireless network. A gateway software piece receives and processes the data from the wireless network and stores these data in a computer memory associated with a database software piece. The system also includes an Internet-based user interface that displays the vital sign data for both individual patients and care-providers.

The present invention relates to a physiological monitoring device. Some embodiments of the invention allow for long-term monitoring of physiological signals. Further embodiments may also allow for the monitoring of secondary signals such as motion.

A method of in situ analysis of a biological sample comprising the steps of (a) staining the biological sample with N stains of which a first stain is selected from the group consisting of a first immunohistochemical stain, a first histological stain and a first DNA ploidy stain, and a second stain is selected from the group consisting of a second immunohistochemical stain, a second histological stain and a second DNA ploidy stain, with provisions that N is an integer greater than three and further that (i) if the first stain is the first immunohistochemical stain then the second stain is either the second histological stain or the second DNA ploidy stain; (ii) if the first stain is the first histological stain then the second stain is either the second immunohistochemical stain or the second DNA ploidy stain; whereas (iii) if the first stain is the first DNA ploidy stain then the second stain is either the second immunohistochemical stain or the second histological stain; and (b) using a spectral data collection device for collecting spectral data from the biological sample, the spectral data collection device and the N stains are selected such that a spectral component associated with each of the N stains is collectable.

Detection of placement of dental aligners in patient mouth on teeth for indication of wearing compliance. Described herein are apparatuses and methods for detecting wearing, including compliance, and for reliably transferring data, by wired or wireless direct or indirect communication of electronic compliance information to a smartphone. Also described herein are dental appliances that can detect physiological parameters related to respiration and sleep. Also described herein are aligner cases that enable NFC communication with electronic compliance indicator (ECI) devices and Bluetooth communication with smartphones.

The present invention provides systems and methods for the evaluation of the urethra and periurethral tissues using an MRI coil adapted for insertion into the male, female or pediatric urethra. The MRI coil may be in electrical communication with an interface circuit made up of a tuning-matching circuit, a decoupling circuit and a balun circuit. The interface circuit may also be in electrical communication with a MRI machine. In certain practices, the present invention provides methods for the diagnosis and treatment of conditions involving the urethra and periurethral tissues, including disorders of the female pelvic floor, conditions of the prostate and anomalies of the pediatric pelvis.

The invention provides a device for contacting a surface of a patient's body to determine a physiologic parameter in a measurement region of a tissue of the patient. The device typically comprises a sensor responsive to the physiologic parameter and a probe housing the sensor. The probe is constructed to allow the sensor to be secured at a sensing site adjacent to the measurement region, without disturbing the blood flow within the measurement region of the tissue. The device may also include a means for reducing interference in the sensing area. Preferably, the device further comprises an indicating means operably connected to the sensor for indicating an analyte quantity and/or concentration associated with the physiologic parameter.

An intravascular ultrasound probe is disclosed, incorporating features for utilizing an advanced transducer technology on a rotating transducer shaft. In particular, the probe accommodates the transmission of the multitude of signals across the boundary between the rotary and stationary components of the probe required to support an advanced transducer technology. These advanced transducer technologies offer the potential for increased bandwidth, improved beam profiles, better signal to noise ratio, reduced manufacturing costs, advanced tissue characterization algorithms, and other desirable features. Furthermore, the inclusion of electronic components on the spinning side of the probe can be highly advantageous in terms of preserving maximum signal to noise ratio and signal fidelity, along with other performance benefits.

An electronic endoscope system which captures an image of an object and displays the same on a display device is provided with a noise reduction system. The noise reduction system reduces noise included in a frame of an image signal for each color component. The noise-reduced color components are stored in a buffer, and then output as a video signal to be transmitted to a display where a color image of the object is displayed.

An imaging system, having: an imaging data acquisition device; a remote image reconstruction and data processing facility; and a wireless data transfer to transmit raw data from the data acquisition device to the remote facility. At the facility, the raw data is processed to prepare a diagnostic image that can be transmitted to an expert or non-expert, or transmitted back to the display of the wireless data transfer device.

An apparatus and methods for treating lesions on skin are presented. The apparatus collects information about a lesion and can automatically determine a course of treatment for the lesion. The device can include a controller that positions the nozzle proximate to a surface region of the lesion and automatically dispenses a pulse of the cryogenic fluid from the nozzle. The controller then positions the nozzle proximate to another surface region of the lesion and automatically dispenses a pulse of the cryogenic fluid from the nozzle.

A system and methods of diagnosing and monitoring neurological disorders in a patient utilizing an artificial intelligence based system. The system may comprise a plurality of sensors, a collection of trained machine learning based diagnostic and monitoring tools, and an output device. The plurality of sensors may collect data relevant to neurological disorders. The trained diagnostic tool will learn to use the sensor data to assign risk assessments for various neurological disorders. The trained monitoring tool will track the development of a disorder over time and may be used to recommend or modify the administration of relevant treatments. The goal of the system is to render an accurate evaluation of the presence and severity of neurological disorders in a patient without requiring input from an expertly trained neurologist.

A performance analysis support system is disclosed that provides one or more recommended solutions of a performance improvement project to management and the expected improvement benefit of each solution. The performance analysis support system guides a user through a detailed, consistent analysis process, helping organizational leaders accurately diagnose critical performance or productivity issues. Then, the performance analysis support system estimates the personnel and equipment requirements, time, costs, and return on investment associated with each solution generated based on the analysis results. In addition, the performance analysis support system provides management immediate access to ongoing and past analyses.

The present invention provides a technology called Pulse-Multiline Excitation or PME. This technology provides a novel approach to fluorescence detection with application for high-throughput identification of informative SNPs, which could lead to more accurate diagnosis of inherited disease, better prognosis of risk susceptibilities, or identification of sporadic mutations. The PME technology has two main advantages that significantly increase fluorescence sensitivity: (1) optimal excitation of all fluorophores in the genomic assay and (2) “color-blind” detection, which collects considerably more light than standard wavelength resolved detection. Successful implementation of the PME technology will have broad application for routine usage in clinical diagnostics, forensics, and general sequencing methodologies and will have the capability, flexibility, and portability of targeted sequence variation assays for a large majority of the population.

Disclosed herein are systems, methods, devices, and media for carrying out medical diagnosis of ophthalmic diseases and conditions. Deep learning algorithms enable the automated analysis of ophthalmic images to generate predictions of comparable accuracy to clinical experts.

Catheter for insertion into a vessel, comprising a reversibly inflatable balloon (10, 25) provided in the area of the catheter tip, on the outside of which a stent (11) to be implanted in the vessel is arranged, and at least one imaging device (14, 21, 22) arranged in the area of the catheter tip for optical coherence tomography, which is arranged or configured such that the area of the vessel, in which the balloon (10, 25) is positioned, can be captured.

The invention discloses a fault diagnosis and assessment method of an intelligent substation. The fault diagnosis and assessment method is characterized by including the specific steps that a fault diagnosis and assessment information model of the intelligent substation is constructed; fault and assessment indexes of a primary device, a secondary device and a network device in the intelligent substation are calculated on the basis of the fault diagnosis and assessment information model; a Petri net is used to perform primary fault diagnosis and assessment to the intelligent substation; and final diagnosis and assessment are performed by means of a distributed type expert system based on a knowledge base. The fault diagnosis and assessment method has the advantages of being clear in the diagnosis process, fast and practical in diagnosis methods and accurate and reliable in diagnosis results.